RTX dose 2x500mg | 1.4 (0.6, 2.9), p=0.442 | 1.3 (0.6, 2.8), p=0.507 |
2x1000mg | 2.5 (1.3, 5.0), p=0.009 | 2.4 (1.2, 4.8), p=0.010 |
Number of previous DMARDs | 1.0 (0.8, 1.3), p=0.822 | 1.0 (0.8, 1.3), p=0.840 |
Number of previous bDMARDs | 0.6 (0.4, 1.0), p=0.043 | 0.6 (0.4, 1.0), p=0.040 |
Age, per 10 years | 1.23 (1.01, 1.50), p=0.036 | 1.23 (1.01, 1.50), p=0.038 |
Female | 1.1 (0.6, 1.9), p=0.858 | 1.0 (0.6, 1.9), p=0.902 |
BMI, per unit | 1.0 (0.9, 1.0), p=0.005 | 1.0 (0.9, 1.0), p=0.005 |
Disease duration, per 5 years | 1.1 (0.9, 1.3), p=0.441 | 1.1 (0.9, 1.3), p=0.390 |
Oral steroid use at baseline | 1.3 (0.8, 2.1), p=0.229 | 1.4 (0.8, 2.2), p=0.202 |
DAS28CRP, per unit | 1.2 (0.9, 1.6), p=0.305 | 1.2 (0.9, 1.6), p=0.275 |
HAQ, per unit | 0.8 (0.5, 1.2), p=0.343 | 0.8 (0.5, 1.2), p=0.295 |
IGA, per g/L | 1.2 (1.0, 1.5), p=0.093 | 1.2 (1.0, 1.5), p=0.099 |
IGG, per g/L | 1.1 (1.0, 1.1), p=0.021 | 1.0 (0.9, 1.2), p=0.867 |
IGM, per g/L | 1.0 (0.7, 1.4), p=0.966 | 1.0 (0.7, 1.4), p=0.959 |
IGG x RTX500 | | 1.1 (1.0, 1.3), p=0.140 |
IGG x RTX1000 | | 1.0 (0.9, 1.2), p=0.614 |